Qing Yin

ORCID: 0009-0009-7317-7564
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Peripheral Neuropathies and Disorders
  • Autoimmune Neurological Disorders and Treatments
  • Hearing, Cochlea, Tinnitus, Genetics
  • Vestibular and auditory disorders
  • Hearing Loss and Rehabilitation
  • Folate and B Vitamins Research
  • Cytokine Signaling Pathways and Interactions
  • Genomics and Chromatin Dynamics
  • Ubiquitin and proteasome pathways
  • Genetics and Neurodevelopmental Disorders
  • Asthma and respiratory diseases
  • IL-33, ST2, and ILC Pathways
  • Metabolism and Genetic Disorders
  • Lymphoma Diagnosis and Treatment
  • RNA modifications and cancer
  • Acute Lymphoblastic Leukemia research
  • Iron Metabolism and Disorders
  • Neurological Disorders and Treatments
  • Cytomegalovirus and herpesvirus research
  • Chronic Lymphocytic Leukemia Research

Huazhong University of Science and Technology
2024-2025

Tongji Hospital
2024-2025

Taizhou University
2021-2025

Taizhou Central Hospital
2021-2025

Second Xiangya Hospital of Central South University
2024-2025

Central South University
2024-2025

First Affiliated Hospital of Dalian Medical University
2015

Dalian Medical University
2015

Resistance to chemotherapy is a significant concern in the treatment of nasopharyngeal carcinoma (NPC), and occurs due various mechanisms. This study aimed evaluate effects RING finger protein 138 (RNF138) development cisplatin resistance NPC. After gene overexpression silencing, expression levels RNF138 were evaluated. The impacts on proliferation apoptosis rate NPC cells then assessed. γ-H2AX-mediated DNA damage was determined via immunofluorescence assay. Moreover, tumor xenograft mouse...

10.1038/s41598-025-85716-6 article EN cc-by-nc-nd Scientific Reports 2025-01-09

The long-term clinical outcomes of patients with persistent EBV-DNA positivity after primary EBV infection B cells and the value rituximab in this group are unknown. We retrospectively analyzed EBV-infected at our center from October 2016 to July 2023. They were divided into two groups based on presence infectious mononucleosis. To assess disease transformation under exposure impact clearance, we followed up monitored changes conventional observation treatment subgroup subgroup. Seventy-one...

10.1016/j.intimp.2025.114695 article EN cc-by International Immunopharmacology 2025-04-21

Abstract Objective To delineate the clinical characteristics of antibody‐negative autoimmune encephalitis (AE) and to investigate factors associated with long‐term outcomes among AE. Methods Patients diagnosed AE were recruited from January 2016 December 2022 at Second Xiangya Hospital Central South University. The study assessed using modified Rankin scale (mRS) Clinical Assessment Scale in Autoimmune Encephalitis (CASE). Predictors influencing subsequently analyzed. External validation...

10.1002/acn3.52049 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2024-04-21

Abstract Interferon (IFN) plays a role in immune and inflammation responses. However, the effect of IFN asthma is still not fully clear. The present study was conducted to better understand signatures asthma. Blood samples from case–control studies (study 1: 348 asthmas 39 normal controls validation 2: 411 87 controls) were enrolled. single-sample gene set enrichment analysis (ssGSEA) method used quantify levels 74 signatures. Gene Ontology pathway function performed for functional...

10.1042/bsr20204210 article EN Bioscience Reports 2021-03-01
Coming Soon ...